Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CBER
Biotech
Moderna rare disease drug nabs spot in FDA pilot program
Moderna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s newly launched START pilot program for rare disease.
Helen Floersh
Jun 7, 2024 6:10am
FDA picks Denali, Neurogene and more for rare disease program
Jun 4, 2024 2:51pm
FDA's new platform guidance aims to smooth regulatory encounters
May 30, 2024 7:30am
FDA's Peter Marks doesn't plan to retire soon—Chutes & Ladders
Aug 4, 2023 9:30am
FDA's Marks overrules staff drug reviewers 'with trepidation'
Jul 27, 2023 3:05pm
New federal biotech commission taps 12 members—Chutes & Ladders
Feb 3, 2023 10:20am
